Compartilhar
Informação da revista
Número
Vol. 44. Núm. 1.Páginas 1-142 (Janeiro - Março 2022)
Original articles
Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects’ eligibility?
Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Layane Marques de Souza, Maria do Rosario Ferraz Roberti
Hematol Transfus Cell Ther. 2022;44:1-6
Open access
Effect of ABO blood groups on length of hospital stay according to age in Covid-19 patients
Vildan Gursoy, Suna Avci
Hematol Transfus Cell Ther. 2022;44:7-12
Open access
SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility
Roberto Crocchiolo, Francesco Alfarano, Elisabetta Volpato, Mariateresa Pugliano, Irene Cuppari, Anna Maria Mazza, Laura Bellio, Diana Fanti, ... Silvano Rossini
Hematol Transfus Cell Ther. 2022;44:13-6
Open access
COVID-19 pandemic and blood transfusion services: The impact, response and preparedness experience of a tertiary care blood center in southern Karnataka, India
Dhivya Kandasamy, Shamee Shastry, Deepika Chenna, Ganesh Mohan
Hematol Transfus Cell Ther. 2022;44:17-25
Open access
Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature
Bruno Almeida Costa, Kaiza Vilarinho da Luz, Sarah Emanuelle Viana Campos, Germison Silva Lopes, João Paulo de Vasconcelos Leitão, Fernando Barroso Duarte
Hematol Transfus Cell Ther. 2022;44:26-31
Open access
Acute invasive fungal rhinosinusitis in pediatric patients with oncohematological diseases
Lorrane Caroline Braga Rodrigues, Alessandro Fernandes Guimaraes, Isamara Simas de Oliveira, Pedro Henrique Medici de Sousa, Roberta Maia de Castro Romanelli, Fabiana Maria Kakehasi, Karla Emília de Sá Rodrigues
Hematol Transfus Cell Ther. 2022;44:32-9
Open access
Overview of lymphoma diagnosis in Brazilian public health system patients: Open data analysis for health care planning
Denise Pires Martins, Nelson Francisco Correa-Netto, Nina Melo, Sandra Regina Loggetto, Marcia Mello Costa de Liberal
Hematol Transfus Cell Ther. 2022;44:40-8
Open access
Validation of the single-platform ISHAGE protocol for enumeration of CD34+ hematopoietic stem cells in umbilical cord blood in a Brazilian center
Carla Cristina Pedrosa de Lira de Morais, Juliana Dias Alves Pinto, Karen Wagner de Souza, Marina Izu, Luis Fernando da Silva Bouzas, Flávio Henrique Paraguassú-Braga
Hematol Transfus Cell Ther. 2022;44:49-55
Open access
Lipoprotein apheresis efficacy and challenges: single center experience
Zehra Narlı Özdemir, Uğur Şahin, Yasin Yıldırım, Cansın Tulunay Kaya, Osman İlhan
Hematol Transfus Cell Ther. 2022;44:56-62
Open access
Smudge cells percentage on blood smear is a reliable prognostic marker in chronic lymphocytic leukemia
Abibatou Sall, Moussa Seck, Seynabou Fall, Fatimata Bintou Sall, Blaise Félix Faye, Fatou Samba Ndiaye, Macoura Gadji, Saliou Diop, ... Martine Raphaël
Hematol Transfus Cell Ther. 2022;44:63-9
Open access
Review articles
ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review
Sapha Shibeeb, Aisha Khan
Hematol Transfus Cell Ther. 2022;44:70-5
Open access
Role of preoperative erythropoietin in the optimization of preoperative anemia among surgical patients — A systematic review and meta-analysis
Sheikh Muhammad Ebad Ali, Muhammad Hassan Hafeez, Omar Nisar, Sarosh Fatima, Humaira Ghous, Mahwish Rehman
Hematol Transfus Cell Ther. 2022;44:76-84
Open access
Special content
Special Content
Special articles
Guidelines on sickle cell disease: primary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines project: Associação Médica Brasileira - 2021
Sandra Regina Loggetto, Mônica Pinheiro de Almeida Veríssimo, Luiz Guilherme Darrigo-Junior, Ricardo dos Santos Simões, Wanderley Marques Bernardo, Josefina Aparecida Pellegrini Braga
Hematol Transfus Cell Ther. 2022;44:85-94
Open access
HFE hemochromatosis: an overview about therapeutic recommendations
Rodolfo D. Cancado, Aline Morgan Alvarenga, Paulo Caleb JL Santos
Hematol Transfus Cell Ther. 2022;44:95-9
Open access
Case reports
SARS-COV-2: is it a risk for blood transfusion?
Dante Mário Langhi, Renato Cerqueira de Souza, Melca Barros, Gil Cunha De Santis, Simone Haddad Kashima, Jose Orlando Bordin
Hematol Transfus Cell Ther. 2022;44:100-3
Open access
Gaucher disease. Presentation of a clinical case and literature review
Karen Valdés-Díaz, Raymond Fariña-Lamadrid, Daniel Artiles-Martínez, Jesús A. López
Hematol Transfus Cell Ther. 2022;44:104-7
Open access
Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report
Eduardo Atsushi Osawa, Antonio Adolfo Guerra Soares Brandão, André Dias Américo, Alexandre Toledo Maciel
Hematol Transfus Cell Ther. 2022;44:108-11
Open access
Acute lymphoblastic leukemia to acute myeloid leukemia: an unusual case report of lineage switching
Sudarshan Pandit, Nilesh Wasekar, Girish Badarkhe, Venkata Ramesh Yasam, Rajnish Nagarkar
Hematol Transfus Cell Ther. 2022;44:112-5
Open access
Outcome of patient with Polycythemia Rubra Vera and psychiatric symptoms
Rodrigo Otero Coelho, Luiz Fernando Mohallem Reynaldo, Guilherme da Costa Boni Valente, Luciano Fuzzato Silva
Hematol Transfus Cell Ther. 2022;44:116-9
Open access
Letters to the editor
Regarding management of COVID-19 in acute lymphoblastic leukemia
Mohammad Ammad Ud Din
Hematol Transfus Cell Ther. 2022;44:120-1
Open access
Response to queries about “COVID-19 and adult acute lymphoblastic leukemia: Presentation and management”
Ayesha Butt, Natasha Ali
Hematol Transfus Cell Ther. 2022;44:122-3
Open access
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
Keli Lima, Hugo Passos Vicari, Jorge Antonio Elias Godoy Carlos, Jean Carlos Lipreri da Silva, Lorena Lobo de Figueiredo-Pontes, Eduardo Magalhães Rego, João Agostinho Machado-Neto
Hematol Transfus Cell Ther. 2022;44:124-7
Open access
Acute invasive fungal sinusitis in immunocompromised children
Rejin Kebudi
Hematol Transfus Cell Ther. 2022;44:128-9
Open access
Prevalence of atypical BCR-ABL1 transcript types in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: implications for measurable residual disease
Úna Bhreathnach, Laura Kearney, Stephen E. Langabeer
Hematol Transfus Cell Ther. 2022;44:130-1
Open access
Special content
Special Content
Images in clinical hematology
Anaplastic plasma cell myeloma — A morphological dilemma
Thulasi Raman Ramalingam, Lakshman Vaidhyanathan, Prabu Pandurangan
Hematol Transfus Cell Ther. 2022;44:132-3
Open access
Chloroma — A rare sarcoma
Fernando Silva Xavier, Márcio Luís Duarte, Ricardo Rabello Chiattone
Hematol Transfus Cell Ther. 2022;44:134-5
Open access
Gaucher-like cells in myelodysplastic syndrome with ring sideroblasts
Christelle El Khoury, Hussein Farhat
Hematol Transfus Cell Ther. 2022;44:136-7
Open access
Disseminated histoplasmosis diagnosed in a bone marrow sample
Naseelah Yunus Mussá, Sara Ismail, Dinah Carvalho
Hematol Transfus Cell Ther. 2022;44:138-9
Open access
Diagnosis of indolent systemic mastocytosis in a patient with “seborrheic keratosis”
Habib Moshref Razavi, Samuel Krikler
Hematol Transfus Cell Ther. 2022;44:140-1
Open access
Conteúdo especial sobre COVID-19
- Anti-PF4 antibodies and their relationship with COVID infection
- Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity
- Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases
- Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.